{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "28116038", "DateCompleted": {"Year": "2017", "Month": "03", "Day": "06"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "31"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "12", "Day": "27"}], "Language": ["eng"], "ELocationID": ["8590578", "10.1155/2016/8590578"], "Journal": {"ISSN": "1942-0994", "JournalIssue": {"Volume": "2016", "PubDate": {"Year": "2016"}}, "Title": "Oxidative medicine and cellular longevity", "ISOAbbreviation": "Oxid Med Cell Longev"}, "ArticleTitle": "The Role of Reactive Oxygen Species in the Pathogenesis of Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease: A Mini Review.", "Pagination": {"StartPage": "8590578", "MedlinePgn": "8590578"}, "Abstract": {"AbstractText": ["Neurodegenerative diseases affect not only the life quality of aging populations, but also their life spans. All forms of neurodegenerative diseases have a massive impact on the elderly. The major threat of these brain diseases includes progressive loss of memory, Alzheimer's disease (AD), impairments in the movement, Parkinson's disease (PD), and the inability to walk, talk, and think, Huntington's disease (HD). Oxidative stress and mitochondrial dysfunction are highlighted as a central feature of brain degenerative diseases. Oxidative stress, a condition that occurs due to imbalance in oxidant and antioxidant status, has been known to play a vital role in the pathophysiology of neurodegenerative diseases including AD, PD, and HD. A large number of studies have utilized oxidative stress biomarkers to investigate the severity of these neurodegenerative diseases and medications are available, but these only treat the symptoms. In traditional medicine, a large number of medicinal plants have been used to treat the symptoms of these neurodegenerative diseases. Extensive studies scientifically validated the beneficial effect of natural products against neurodegenerative diseases using suitable animal models. This short review focuses the role of oxidative stress in the pathogenesis of AD, PD, and HD and the protective efficacy of natural products against these diseases."]}, "AuthorList": [{"Identifier": ["0000-0001-5233-9071"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Annamalainagar, Tamil Nadu, India."}], "LastName": "Manoharan", "ForeName": "Shanmugam", "Initials": "S"}, {"Identifier": ["0000-0001-8105-4470"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Neuroinflammation Group, Department of Biomedical Research, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia."}], "LastName": "Guillemin", "ForeName": "Gilles J", "Initials": "GJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Annamalainagar, Tamil Nadu, India."}], "LastName": "Abiramasundari", "ForeName": "Rajagopal Selladurai", "Initials": "RS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Food Science and Nutrition, Sultan Qaboos University, Muscat, Oman."}], "LastName": "Essa", "ForeName": "Musthafa Mohamed", "Initials": "MM"}, {"Identifier": ["0000-0002-8820-7406"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "SMPT, NIAAA, National Institutes of Health, Rockville, MD, USA."}], "LastName": "Akbar", "ForeName": "Mohammed", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "SMPT, NIAAA, National Institutes of Health, Rockville, MD, USA."}], "LastName": "Akbar", "ForeName": "Mohammed D", "Initials": "MD"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Oxid Med Cell Longev", "NlmUniqueID": "101479826", "ISSNLinking": "1942-0994"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Biological Products"}, {"RegistryNumber": "0", "NameOfSubstance": "Reactive Oxygen Species"}], "MeshHeadingList": [{"QualifierName": ["drug therapy", "metabolism", "pathology"], "DescriptorName": "Alzheimer Disease"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Biological Products"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "metabolism", "pathology"], "DescriptorName": "Huntington Disease"}, {"QualifierName": [], "DescriptorName": "Oxidative Stress"}, {"QualifierName": ["drug therapy", "metabolism", "pathology"], "DescriptorName": "Parkinson Disease"}, {"QualifierName": ["metabolism"], "DescriptorName": "Reactive Oxygen Species"}], "CoiStatement": "The authors declare that there is no conflict of interests regarding the publication of this paper."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Uttara B., Singh A. V., Zamboni P., Mahajan R. T. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Current Neuropharmacology. 2009;7(1):65\u201374. doi: 10.2174/157015909787602823.", "ArticleIdList": ["10.2174/157015909787602823", "PMC2724665", "19721819"]}, {"Citation": "Rossor M. N., Fox N. C., Mummery C. J., Schott J. M., Warren J. D. The diagnosis of young-onset dementia. The Lancet Neurology. 2010;9(8):793\u2013806. doi: 10.1016/S1474-4422(10)70159-9.", "ArticleIdList": ["10.1016/S1474-4422(10)70159-9", "PMC2947856", "20650401"]}, {"Citation": "Lin M. T., Beal M. F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature. 2006;443:787\u2013795. doi: 10.1038/nature05292.", "ArticleIdList": ["10.1038/nature05292", "17051205"]}, {"Citation": "Butterfield D. A., Boyd-Kimball D. Amyloid \u03b2-peptide(1-42) contributes to the oxidative stress and neurodegeneration found in Alzheimer disease brain. Brain Pathology. 2004;14(4):426\u2013432.", "ArticleIdList": ["PMC8096022", "15605990"]}, {"Citation": "Lemere C. A., Masliah E. Can Alzheimer disease be prevented by amyloid-\u03b2 immunotherapy? Nature Reviews Neurology. 2010;6(2):108\u2013119. doi: 10.1038/nrneurol.2009.219.", "ArticleIdList": ["10.1038/nrneurol.2009.219", "PMC2864089", "20140000"]}, {"Citation": "Mosconi L., Pupi A., De Leon M. J. Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease. Annals of the New York Academy of Sciences. 2008;1147:180\u2013195. doi: 10.1196/annals.1427.007.", "ArticleIdList": ["10.1196/annals.1427.007", "PMC2661241", "19076441"]}, {"Citation": "Ferri C. P., Prince M., Brayne C., et al. Global prevalence of dementia: a Delphi consensus study. The Lancet. 2005;366(9503):2112\u20132117. doi: 10.1016/s0140-6736(05)67889-0.", "ArticleIdList": ["10.1016/s0140-6736(05)67889-0", "PMC2850264", "16360788"]}, {"Citation": "Pratic\u00f2 D. Evidence of oxidative stress in Alzheimer's disease brain and antioxidant therapy: lights and shadows. Annals of the New York Academy of Sciences. 2008;1147:70\u201378. doi: 10.1196/annals.1427.010.", "ArticleIdList": ["10.1196/annals.1427.010", "19076432"]}, {"Citation": "Joseph F. P., Darrell Jennings C., Richard J. K., et al. Association of HFE mutations with neurodegeneration and oxidative stress in Alzheimer's disease and correlation with APOE. American Journal of Medical Genetics. 2003;119:48\u201353.", "ArticleIdList": ["12707938"]}, {"Citation": "Bird T. D. Genetic aspects of Alzheimer disease. Genetics in Medicine. 2008;10(4):231\u2013239. doi: 10.1097/gim.0b013e31816b64dc.", "ArticleIdList": ["10.1097/gim.0b013e31816b64dc", "PMC2690397", "18414205"]}, {"Citation": "Verbon E. H., Post J. A., Boonstra J. The influence of reactive oxygen species on cell cycle progression in mammalian cells. Gene. 2012;511(1):1\u20136. doi: 10.1016/j.gene.2012.08.038.", "ArticleIdList": ["10.1016/j.gene.2012.08.038", "22981713"]}, {"Citation": "Son Y., Kim S., Chung H.-T., Pae H.-O. Reactive oxygen species in the activation of MAP kinases. Methods in Enzymology. 2013;528:27\u201348. doi: 10.1016/B978-0-12-405881-1.00002-1.", "ArticleIdList": ["10.1016/B978-0-12-405881-1.00002-1", "23849857"]}, {"Citation": "Knock G. A., Ward J. P. T. Redox regulation of protein kinases as a modulator of vascular function. Antioxidants and Redox Signaling. 2011;15(6):1531\u20131547. doi: 10.1089/ars.2010.3614.", "ArticleIdList": ["10.1089/ars.2010.3614", "20849377"]}, {"Citation": "Lo Conte M., Carroll K. S. The redox biochemistry of protein sulfenylation and sulfinylation. The Journal of Biological Chemistry. 2013;288(37):26480\u201326488. doi: 10.1074/jbc.r113.467738.", "ArticleIdList": ["10.1074/jbc.r113.467738", "PMC3772195", "23861405"]}, {"Citation": "Chen X., Guo C., Kong J. Oxidative stress in neurodegenerative diseases. Neural Regeneration Research. 2012;7(5):376\u2013385.", "ArticleIdList": ["PMC4350122", "25774178"]}, {"Citation": "Xie Z., Wei M., Morgan T. E., et al. Peroxynitrite mediates neurotoxicity of amyloid beta-peptide1-42- and lipopolysaccharide-activated microglia. The Journal of Neuroscience. 2002;22(9):3484\u20133492.", "ArticleIdList": ["PMC6758387", "11978825"]}, {"Citation": "Van Dyke K. The possible role of peroxynitrite in Alzheimer's disease: a simple hypothesis that could be tested more thoroughly. Medical Hypotheses. 1997;48(5):375\u2013380. doi: 10.1016/s0306-9877(97)90031-1.", "ArticleIdList": ["10.1016/s0306-9877(97)90031-1", "9185121"]}, {"Citation": "Nakajima K., Kohsaka S. Microglia: activation and their significance in the central nervous system. Journal of Biochemistry. 2001;130(2):169\u2013175. doi: 10.1093/oxfordjournals.jbchem.a002969.", "ArticleIdList": ["10.1093/oxfordjournals.jbchem.a002969", "11481032"]}, {"Citation": "Friedman J. Why is the nervous system vulnerable to oxidative stress? In: Gadoth N., G\u00f6bel H. H., editors. Oxidative Stress in Applied Basic Research and Clinical Practice. Totowa, NJ, USA: Humana Press; 2011. pp. 19\u201327.", "ArticleIdList": ["10.1007/978-1-60327-514-9"]}, {"Citation": "Munk\u00e1csy E., Rea S. L. The paradox of mitochondrial dysfunction and extended longevity. Experimental Gerontology. 2014;56:221\u2013233. doi: 10.1016/j.exger.2014.03.016.", "ArticleIdList": ["10.1016/j.exger.2014.03.016", "PMC4104296", "24699406"]}, {"Citation": "Yatin S. M., Yatin M., Aulick T., Ain K. B., Butterfield D. A. Alzheimer's amyloid \u03b2-peptide associated free radicals increase rat embryonic neuronal polyamine uptake and ornithine decarboxylase activity: protective effect of vitamin E. Neuroscience Letters. 1999;263(1):17\u201320. doi: 10.1016/s0304-3940(99)00101-9.", "ArticleIdList": ["10.1016/s0304-3940(99)00101-9", "10218900"]}, {"Citation": "Butterfield D. A., Lauderback C. M. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid \u03b2-peptide-associated free radical oxidative stress. Free Radical Biology and Medicine. 2002;32(11):1050\u20131060. doi: 10.1016/s0891-5849(02)00794-3.", "ArticleIdList": ["10.1016/s0891-5849(02)00794-3", "12031889"]}, {"Citation": "Drake J., Link C. D., Butterfield D. A. Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid \u03b2-peptide (1\u201342) in a transgenic Caenorhabditis elegans model. Neurobiology of Aging. 2003;24(3):415\u2013420. doi: 10.1016/s0197-4580(02)00225-7.", "ArticleIdList": ["10.1016/s0197-4580(02)00225-7", "12600717"]}, {"Citation": "Massaad C. A. Neuronal and vascular oxidative stress in Alzheimer's disease. Current Neuropharmacology. 2011;9(4):662\u2013673. doi: 10.2174/157015911798376244.", "ArticleIdList": ["10.2174/157015911798376244", "PMC3263460", "22654724"]}, {"Citation": "Baldeiras I., Santana I., Proen\u00e7a M. T., et al. Peripheral oxidative damage in mild cognitive impairment and mild Alzheimer's disease. Journal of Alzheimer's Disease. 2008;15(1):117\u2013128.", "ArticleIdList": ["18780972"]}, {"Citation": "Greilberger J., Koidl C., Greilberger M., et al. Malondialdehyde, carbonyl proteins and albumin-disulphide as useful oxidative markers in mild cognitive impairment and Alzheimer's disease. Free Radical Research. 2008;42(7):633\u2013638. doi: 10.1080/10715760802255764.", "ArticleIdList": ["10.1080/10715760802255764", "18654878"]}, {"Citation": "Palmer A. M., Burns M. A. Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer's disease. Brain Research. 1994;645(1-2):338\u2013342. doi: 10.1016/0006-8993(94)91670-5.", "ArticleIdList": ["10.1016/0006-8993(94)91670-5", "8062096"]}, {"Citation": "Lovell M. A., Ehmann W. D., Butler S. M., Markesbery W. R. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology. 1995;45(8):1594\u20131601. doi: 10.1212/WNL.45.8.1594.", "ArticleIdList": ["10.1212/WNL.45.8.1594", "7644059"]}, {"Citation": "Marcus D. L., Thomas C., Rodriguez C., et al. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Experimental Neurology. 1998;150(1):40\u201344. doi: 10.1006/exnr.1997.6750.", "ArticleIdList": ["10.1006/exnr.1997.6750", "9514828"]}, {"Citation": "Gabbita S. P., Lovell M. A., Markesbery W. R. Increased nuclear DNA oxidation in the brain in Alzheimer' s disease. Journal of Neurochemistry. 1998;71(5):2034\u20132040.", "ArticleIdList": ["9798928"]}, {"Citation": "Hensley K., Hall N., Subramaniam R., et al. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. Journal of Neurochemistry. 1995;65(5):2146\u20132156.", "ArticleIdList": ["7595501"]}, {"Citation": "Smith M. A., Harris P. L. R., Sayre L. M., Perry G. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proceedings of the National Academy of Sciences of the United States of America. 1997;94(18):9866\u20139868. doi: 10.1073/pnas.94.18.9866.", "ArticleIdList": ["10.1073/pnas.94.18.9866", "PMC23283", "9275217"]}, {"Citation": "Lovell M. A., Robertson J. D., Teesdale W. J., Campbell J. L., Markesbery W. R. Copper, iron and zinc in Alzheimer's disease senile plaques. Journal of the Neurological Sciences. 1998;158(1):47\u201352. doi: 10.1016/s0022-510x(98)00092-6.", "ArticleIdList": ["10.1016/s0022-510x(98)00092-6", "9667777"]}, {"Citation": "Casadesus G., Smith M. A., Zhu X., et al. Alzheimer disease: evidence for a central pathogenic role of iron-mediated reactive oxygen species. Journal of Alzheimer's Disease. 2004;6(2):165\u2013169.", "ArticleIdList": ["15096700"]}, {"Citation": "Rottkamp C. A., Raina A. K., Zhu X., et al. Redox-active iron mediates amyloid-\u03b2 toxicity. Free Radical Biology and Medicine. 2001;30(4):447\u2013450. doi: 10.1016/S0891-5849(00)00494-9.", "ArticleIdList": ["10.1016/S0891-5849(00)00494-9", "11182300"]}, {"Citation": "Rowan M. J., Klyubin I., Wang Q., Anwyl R. Mechanisms of the inhibitory effects of amyloid \u03b2-protein on synaptic plasticity. Experimental Gerontology. 2004;39(11-12):1661\u20131667. doi: 10.1016/j.exger.2004.06.020.", "ArticleIdList": ["10.1016/j.exger.2004.06.020", "15582282"]}, {"Citation": "Karelson E., Bogdanovic N., Garlind A., et al. The cerebrocortical areas in normal brain aging and in Alzheimer's disease: noticeable differences in the lipid peroxidation level and in antioxidant defense. Neurochemical Research. 2001;26(4):353\u2013361. doi: 10.1023/a:1010942929678.", "ArticleIdList": ["10.1023/a:1010942929678", "11495345"]}, {"Citation": "Castellani R., Hirai K., Aliev G., et al. Role of mitochondrial dysfunction in Alzheimer's disease. Journal of Neuroscience Research. 2002;70(3):357\u2013360. doi: 10.1002/jnr.10389.", "ArticleIdList": ["10.1002/jnr.10389", "12391597"]}, {"Citation": "Gibson G. E., Sheu K.-F. R., Blass J. P. Abnormalities of mitochondrial enzymes in Alzheimer disease. Journal of Neural Transmission. 1998;105(8-9):855\u2013870. doi: 10.1007/s007020050099.", "ArticleIdList": ["10.1007/s007020050099", "9869323"]}, {"Citation": "Yatin S. M., Varadarajan S., Butterfield D. A. Vitamin E prevents Alzheimer's amyloid \u03b2-peptide (1-42)-induced neuronal protein oxidation and reactive oxygen species production. Journal of Alzheimer's Disease. 2000;2(2):123\u2013131.", "ArticleIdList": ["12214102"]}, {"Citation": "Abramov A. Y., Canevari L., Duchen M. R. Changes in intracellular calcium and glutathione in astrocytes as the primary mechanism of amyloid neurotoxicity. Journal of Neuroscience. 2003;23(12):5088\u20135095.", "ArticleIdList": ["PMC6741151", "12832532"]}, {"Citation": "Melo J. B., Agostinho P., Oliveira C. R. Involvement of oxidative stress in the enhancement of acetylcholinesterase activity induced by amyloid beta-peptide. Neuroscience Research. 2003;45(1):117\u2013127. doi: 10.1016/S0168-0102(02)00201-8.", "ArticleIdList": ["10.1016/S0168-0102(02)00201-8", "12507730"]}, {"Citation": "Rahman K. Studies on free radicals, antioxidants, and co-factors. Clinical Interventions in Aging. 2007;2(2):219\u2013236.", "ArticleIdList": ["PMC2684512", "18044138"]}, {"Citation": "Singhal A., Bangar O., Naithani V. Medicinal plants with a potential to treat Alzheimer and associated symptoms. International Journal of Nutrition, Pharmacology, Neurological Diseases. 2012;2(2):84\u201391. doi: 10.4103/2231-0738.95927.", "ArticleIdList": ["10.4103/2231-0738.95927"]}, {"Citation": "Upadhyay P., Panjwani D., Yadav A. K. Neuropathology staging and treatment strategies of Alzheimer's disease: an update. International Journal of Nutrition, Pharmacology, Neurological Diseases. 2014;4(1):28\u201342. doi: 10.4103/2231-0738.124612.", "ArticleIdList": ["10.4103/2231-0738.124612"]}, {"Citation": "Kim G. H., Kim J. E., Rhie S. J., Yoon S. The role of oxidative stress in neurodegenerative diseases. Experimental Neurobiology. 2015;24(4):325\u2013340. doi: 10.5607/en.2015.24.4.325.", "ArticleIdList": ["10.5607/en.2015.24.4.325", "PMC4688332", "26713080"]}, {"Citation": "Ven Murthy M. R., Ranjekar P. K., Ramassamy C., Deshpande M. Scientific basis for the use of Indian ayurvedic medicinal plants in the treatment of neurodegenerative disorders: 1. Ashwagandha. Central Nervous System Agents in Medicinal Chemistry. 2010;10(3):238\u2013246. doi: 10.2174/1871524911006030238.", "ArticleIdList": ["10.2174/1871524911006030238", "20528765"]}, {"Citation": "Veerendra Kumar M. H., Gupta Y. K. Effect of Centella asiatica on cognition and oxidative stress in an intracerebroventricular streptozotocin model of Alzheimer's disease in rats. Clinical and Experimental Pharmacology and Physiology. 2003;30(5-6):336\u2013342. doi: 10.1046/j.1440-1681.2003.03842.x.", "ArticleIdList": ["10.1046/j.1440-1681.2003.03842.x", "12859423"]}, {"Citation": "Dhanasekaran M., Holcomb L. A., Hitt A. R., et al. Centella asiatica extract selectively decreases amyloid \u03b2 levels in hippocampus of alzheimer's disease animal model. Phytotherapy Research. 2009;23(1):14\u201319. doi: 10.1002/ptr.2405.", "ArticleIdList": ["10.1002/ptr.2405", "19048607"]}, {"Citation": "Clementi M. E., Tringali G., Triggiani D., Giardina B. Aloe arborescens extract protects IMR-32 Cells against Alzheimer amyloid beta peptide via inhibition of radical peroxide production. Natural Product Communications. 2015;10(11):1993\u20131995.", "ArticleIdList": ["26749845"]}, {"Citation": "Gong Y.-S., Guo J., Hu K., et al. Ameliorative effect of lotus seedpod proanthocyanidins on cognitive impairment and brain aging induced by D-galactose. Experimental Gerontology. 2016;74:21\u201328. doi: 10.1016/j.exger.2015.11.020.", "ArticleIdList": ["10.1016/j.exger.2015.11.020", "26657492"]}, {"Citation": "Turgut N. H., Kara H., Arslanba\u015f E., Mert D. G., Tepe B., G\u00fcng\u00f6r H. Effect of Capparis spinosa L. On cognitive impairment induced by D-galactose in mice via inhibition of oxidative stress. Turkish Journal of Medical Sciences. 2015;45(5):1127\u20131136. doi: 10.3906/sag-1405-95.", "ArticleIdList": ["10.3906/sag-1405-95", "26738358"]}, {"Citation": "Yu X.-L., Li Y.-N., Zhang H., et al. Rutin inhibits amylin-induced neurocytotoxicity and oxidative stress. Food and Function. 2015;6(10):3296\u20133306. doi: 10.1039/c5fo00500k.", "ArticleIdList": ["10.1039/c5fo00500k", "26242245"]}, {"Citation": "Mairuae N., Connor J. R., Lee S. Y., Cheepsunthorn P., Tongjaroenbuangam W. The effects of okra (Abelmoschus esculentus Linn.) on the cellular events associated with Alzheimer's disease in a stably expressed HFE neuroblastoma SH-SY5Y cell line. Neuroscience Letters. 2015;31(603):6\u201311. doi: 10.1016/j.neulet.2015.07.011.", "ArticleIdList": ["10.1016/j.neulet.2015.07.011", "26170247"]}, {"Citation": "Uddin M. N., Afrin R., Uddin M. J., et al. Vanda roxburghii chloroform extract as a potential source of polyphenols with antioxidant and cholinesterase inhibitory activities: identification of a strong phenolic antioxidant. BMC Complementary and Alternative Medicine. 2015;15(1, article 195) doi: 10.1186/s12906-015-0728-y.", "ArticleIdList": ["10.1186/s12906-015-0728-y", "PMC4477535", "26100408"]}, {"Citation": "Barbagallo M., Marotta F., Dominguez L. J. Oxidative stress in patients with Alzheimer's disease: effect of extracts of fermented papaya powder. Mediators of Inflammation. 2015;2015:6. doi: 10.1155/2015/624801.624801", "ArticleIdList": ["10.1155/2015/624801", "PMC4405021", "25944987"]}, {"Citation": "Lu K., Zhang C., Wu W., Zhou M., Tang Y., Peng Y. Rhubarb extract has a protective role against radiation-induced brain injury and neuronal cell apoptosis. Molecular Medicine Reports. 2015;12(2):2689\u20132694. doi: 10.3892/mmr.2015.3693.", "ArticleIdList": ["10.3892/mmr.2015.3693", "25936269"]}, {"Citation": "Giacoppo S., Galuppo M., Montaut S., et al. An overview on neuroprotective effects of isothiocyanates for the treatment of neurodegenerative diseases. Fitoterapia. 2015;106:12\u201321. doi: 10.1016/j.fitote.2015.08.001.", "ArticleIdList": ["10.1016/j.fitote.2015.08.001", "26254971"]}, {"Citation": "Zhao L., Liu S., Wang Y., et al. Effects of curculigoside on memory impairment and bone loss via anti-oxidative character in APP/PS1 mutated transgenic mice. PLoS ONE. 2015;10(7) doi: 10.1371/journal.pone.0133289.e0133289", "ArticleIdList": ["10.1371/journal.pone.0133289", "PMC4505858", "26186010"]}, {"Citation": "Muthaiyah B., Essa M. M., Chauhan V., Chauhan A. Protective effects of walnut extract against amyloid beta peptide-induced cell death and oxidative stress in PC12 cells. Neurochemical Research. 2011;36(11):2096\u20132103. doi: 10.1007/s11064-011-0533-z.", "ArticleIdList": ["10.1007/s11064-011-0533-z", "PMC3183245", "21706234"]}, {"Citation": "Hartman R. E., Shah A., Fagan A. M., et al. Pomegranate juice decreases amyloid load and improves behavior in a mouse model of Alzheimer's disease. Neurobiology of Disease. 2006;24(3):506\u2013515. doi: 10.1016/j.nbd.2006.08.006.", "ArticleIdList": ["10.1016/j.nbd.2006.08.006", "17010630"]}, {"Citation": "Subash S., Essa M. M., Al-Asmi A., Al-Adawi S., Vaishnav R., Guillemin G. J. Effect of dietary supplementation of dates in Alzheimer\u2019s disease APPsw/2576 transgenic mice on oxidative stress and antioxidant status. Nutritional Neuroscience. 2015;18(6):281\u2013288. doi: 10.1179/1476830514Y.0000000134.", "ArticleIdList": ["10.1179/1476830514Y.0000000134", "24954036"]}, {"Citation": "Nakajima A., Aoyama Y., Shin E.-J., et al. Nobiletin, a citrus flavonoid, improves cognitive impairment and reduces soluble A\u03b2 levels in a triple transgenic mouse model of Alzheimer's disease (3XTg-AD) Behavioural Brain Research. 2015;289:69\u201377. doi: 10.1016/j.bbr.2015.04.028.", "ArticleIdList": ["10.1016/j.bbr.2015.04.028", "25913833"]}, {"Citation": "Sun A., Xu X., Lin J., Cui X., Xu R. Neuroprotection by saponins. Phytotherapy Research. 2015;29(2):187\u2013200. doi: 10.1002/ptr.5246.", "ArticleIdList": ["10.1002/ptr.5246", "25408503"]}, {"Citation": "Prasanthi J. R. P., Dasari B., Marwarha G., et al. Caffeine protects against oxidative stress and Alzheimer's disease-like pathology in rabbit hippocampus induced by cholesterol-enriched diet. Free Radical Biology and Medicine. 2010;49(7):1212\u20131220. doi: 10.1016/j.freeradbiomed.2010.07.007.", "ArticleIdList": ["10.1016/j.freeradbiomed.2010.07.007", "PMC2930139", "20638472"]}, {"Citation": "Boyd-Kimball D., Sultana R., Mohmmad Abdul H., Butterfield D. A. \u03b3-glutamylcysteine ethyl ester-induced up-regulation of glutathione protects neurons against A\u03b2(1-42)-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease. Journal of Neuroscience Research. 2005;79(5):700\u2013706. doi: 10.1002/jnr.20394.", "ArticleIdList": ["10.1002/jnr.20394", "15678514"]}, {"Citation": "Hanish Singh J. C., Alagarsamy V., Sathesh Kumar S., Narsimha Reddy Y. Neurotransmitter metabolic enzymes and antioxidant status on Alzheimer's disease induced mice treated with Alpinia galanga (L.) Willd. Phytotherapy Research. 2011;25(7):1061\u20131067. doi: 10.1002/ptr.3364.", "ArticleIdList": ["10.1002/ptr.3364", "21280111"]}, {"Citation": "Akbar M., Song B.-J., Essa M. M., Khan M. A. Pomegranate: an ideal fruit for human health. International Journal of Nutrition, Pharmacology, Neurological Diseases. 2015;5(4):141\u2013143. doi: 10.4103/2231-0738.167506.", "ArticleIdList": ["10.4103/2231-0738.167506"]}, {"Citation": "Subash S., Essa M. M., Braidy N., et al. Diet rich in date palm fruits improves memory, learning and reduces beta amyloid in transgenic mouse model of Alzheimer's disease. Journal of Ayurveda and Integrative Medicine. 2015;6(2):111\u2013120. doi: 10.4103/0975-9476.159073.", "ArticleIdList": ["10.4103/0975-9476.159073", "PMC4484046", "26167001"]}, {"Citation": "Subash S., Braidy N., Essa M. M., et al. Long-term (15\u2009mo) dietary supplementation with pomegranates from Oman attenuates cognitive and behavioral deficits in a transgenic mice model of Alzheimer's disease. Nutrition. 2015;31(1):223\u2013229. doi: 10.1016/j.nut.2014.06.004.", "ArticleIdList": ["10.1016/j.nut.2014.06.004", "25441596"]}, {"Citation": "Subash S., Essa M., Al-Asmi A., et al. Pomegranate from oman alleviates the brain oxidative damage in transgenic mouse model of alzheimer\u2032s disease. Journal of Traditional and Complementary Medicine. 2014;4(4):232\u2013238. doi: 10.4103/2225-4110.139107.", "ArticleIdList": ["10.4103/2225-4110.139107", "PMC4220500", "25379464"]}, {"Citation": "Subash S., Essa M. M., Al-Adawi S., Memon M. A., Manivasagam T., Akbar M. Neuroprotective effects of berry fruits on neurodegenerative diseases. Neural Regeneration Research. 2014;9(16):1557\u20131566. doi: 10.4103/1673-5374.139483.", "ArticleIdList": ["10.4103/1673-5374.139483", "PMC4192974", "25317174"]}, {"Citation": "Subash S., Essa M. M., Al-Asmi A., Al-Adawi S., Vaishnav R. Chronic dietary supplementation of 4% figs on the modification of oxidative stress in Alzheimer's disease transgenic mouse model. BioMed Research International. 2014;2014:8. doi: 10.1155/2014/546357.546357", "ArticleIdList": ["10.1155/2014/546357", "PMC4090508", "25050360"]}, {"Citation": "Subash S., Essa M. M., Braidy N., et al. Consumption of fig fruits grown in Oman can improve memory, anxiety, and learning skills in a transgenic mice model of Alzheimer's disease. Nutritional Neuroscience. 2016;19(10):475\u2013483. doi: 10.1179/1476830514y.0000000131.", "ArticleIdList": ["10.1179/1476830514y.0000000131", "24938828"]}, {"Citation": "Essa M. M., Subash S., Dhanalakshmi C., et al. Dietary supplementation of walnut partially reverses 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced neurodegeneration in a mouse model of Parkinson\u2019s disease. Neurochemical Research. 2015;40(6):1283\u20131293. doi: 10.1007/s11064-015-1593-2.", "ArticleIdList": ["10.1007/s11064-015-1593-2", "25944473"]}, {"Citation": "Essa M. M., Subash S., Akbar M., Al-Adawi S., Guillemin G. J. Long-Term dietary supplementation of pomegranates, figs and dates alleviate neuroinflammation in a transgenic mouse model of alzheimer's disease. PLOS ONE. 2015;25(10) doi: 10.1371/journal.pone.0120964.e0120964", "ArticleIdList": ["10.1371/journal.pone.0120964", "PMC4373715", "25807081"]}, {"Citation": "Muthaiyah B., Essa M. M., Lee M., Chauhan V., Kaur K., Chauhan A. Dietary supplementation of walnuts improves memory deficits and learning skills in transgenic mouse model of Alzheimer's disease. Journal of Alzheimer's Disease. 2014;42(4):1397\u20131405. doi: 10.3233/jad-140675.", "ArticleIdList": ["10.3233/jad-140675", "25024344"]}, {"Citation": "Goldenberg M. M. Medical management of Parkinson's disease. P and T. 2008;33(10):590\u2013606.", "ArticleIdList": ["PMC2730785", "19750042"]}, {"Citation": "DeMaagd G., Philip A. Parkinson's disease and its management: part 1: disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis. Pharmacy and Therapeutics. 2015;40(8):504\u2013532.", "ArticleIdList": ["PMC4517533", "26236139"]}, {"Citation": "Massano J., Bhatia K. P. Clinical approach to Parkinson's disease: features, diagnosis, and principles of management. Cold Spring Harbor Perspectives in Medicine. 2012;2(6) doi: 10.1101/cshperspect.a008870.a008870", "ArticleIdList": ["10.1101/cshperspect.a008870", "PMC3367535", "22675666"]}, {"Citation": "Leverenz J. B., Quinn J. F., Zabetian C., Zhang J., Montine K. S., Montine T. J. Cognitive impairment and dementia in patients with Parkinson disease. Current Topics in Medicinal Chemistry. 2009;9(10):903\u2013912. doi: 10.2174/156802609789378218.", "ArticleIdList": ["10.2174/156802609789378218", "PMC2804995", "19754405"]}, {"Citation": "Savitt J. M., Dawson V. L., Dawson T. M. Diagnosis and treatment of Parkinson disease: molecules to medicine. Journal of Clinical Investigation. 2006;116(7):1744\u20131754. doi: 10.1172/jci29178.", "ArticleIdList": ["10.1172/jci29178", "PMC1483178", "16823471"]}, {"Citation": "Parker W. D., Jr., Parks J. K., Swerdlow R. H. Complex I deficiency in Parkinson's disease frontal cortex. Brain Research. 2008;1189:215\u2013218. doi: 10.1016/j.brainres.2007.10.061.", "ArticleIdList": ["10.1016/j.brainres.2007.10.061", "PMC2295283", "18061150"]}, {"Citation": "Alexander G. E. Biology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder. Dialogues in Clinical Neuroscience. 2004;6(3):259\u2013280.", "ArticleIdList": ["PMC3181806", "22033559"]}, {"Citation": "Sarkar S., Raymick J., Imam S. Neuroprotective and therapeutic strategies against Parkinson\u2019s disease: recent perspectives. International Journal of Molecular Sciences. 2016;17(6, article no. 904) doi: 10.3390/ijms17060904.", "ArticleIdList": ["10.3390/ijms17060904", "PMC4926438", "27338353"]}, {"Citation": "Albin R. L. Parkinson's disease: background, diagnosis, and initial management. Clinics in Geriatric Medicine. 2006;22(4):735\u2013751. doi: 10.1016/j.cger.2006.06.003.", "ArticleIdList": ["10.1016/j.cger.2006.06.003", "17000333"]}, {"Citation": "Dorsey E. R., Constantinescu R., Thompson J. P., et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. 2007;68(5):384\u2013386. doi: 10.1212/01.wnl.0000247740.47667.03.", "ArticleIdList": ["10.1212/01.wnl.0000247740.47667.03", "17082464"]}, {"Citation": "Hardy J. Genetic analysis of pathways to parkinson disease. Neuron. 2010;68(2):201\u2013206. doi: 10.1016/j.neuron.2010.10.014.", "ArticleIdList": ["10.1016/j.neuron.2010.10.014", "PMC2997424", "20955928"]}, {"Citation": "Friedlich A. L., Smith M. A., Zhu X., et al. Oxidative stress in Parkinson's disease. The Open Pathology Journal. 2009;3(1):38\u201342. doi: 10.2174/1874375700903010038.", "ArticleIdList": ["10.2174/1874375700903010038"]}, {"Citation": "Cadet J. L., Brannock C. Invited review Free radicals and the pathobiology of brain dopamine systems. Neurochemistry International. 1998;32(2):117\u2013131. doi: 10.1016/s0197-0186(97)00031-4.", "ArticleIdList": ["10.1016/s0197-0186(97)00031-4", "9542724"]}, {"Citation": "Zecca L., Shima T., Stroppolo A., et al. Interaction of neuromelanin and iron in substantia nigra and other areas of human brain. Neuroscience. 1996;73(2):407\u2013415. doi: 10.1016/0306-4522(96)00047-4.", "ArticleIdList": ["10.1016/0306-4522(96)00047-4", "8783258"]}, {"Citation": "Gerlach M., Double K. L., Ben-Shachar D., Zecca L., Youdim M. B. H., Riederer P. Neuromelanin and its interaction with iron as a potential risk factor for dopaminergic neurodegeneration underlying Parkinson's disease. Neurotoxicity Research. 2003;5(1-2):35\u201343. doi: 10.1007/BF03033371.", "ArticleIdList": ["10.1007/BF03033371", "12832223"]}, {"Citation": "Gorell J. M., Ordidge R. J., Brown G. G., Deniau J.-C., Buderer N. M., Helpern J. A. Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease. Neurology. 1995;45(6):1138\u20131143. doi: 10.1212/WNL.45.6.1138.", "ArticleIdList": ["10.1212/WNL.45.6.1138", "7783878"]}, {"Citation": "Friedlich A. L., Beal M. F. Prospects for redox-based therapy in neurodegenerative diseases. Neurotoxicity Research. 2000;2(2-3):229\u2013237. doi: 10.1007/BF03033796.", "ArticleIdList": ["10.1007/BF03033796", "16787843"]}, {"Citation": "Atasoy H. T., Nuyan O., Tunc T., Yorubulut M., Unal A. E., Inan L. E. T2-weighted MRI in Parkinson's disease; substantia nigra pars compacta hypointensity correlates with the clinical scores. Neurology India. 2004;52(3):332\u2013337.", "ArticleIdList": ["15472421"]}, {"Citation": "Kikuchi A., Takeda A., Onodera H., et al. Systemic increase of oxidative nucleic acid damage in Parkinson's disease and multiple system atrophy. Neurobiology of Disease. 2002;9(2):244\u2013248. doi: 10.1006/nbdi.2002.0466.", "ArticleIdList": ["10.1006/nbdi.2002.0466", "11895375"]}, {"Citation": "Faucheux B. A., Martin M.-E., Beaumont C., Hauw J.-J., Agid Y., Hirsch E. C. Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease. Journal of Neurochemistry. 2003;86(5):1142\u20131148. doi: 10.1046/j.1471-4159.2003.01923.x.", "ArticleIdList": ["10.1046/j.1471-4159.2003.01923.x", "12911622"]}, {"Citation": "Dexter D. T., Carter C. J., Wells F. R., et al. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. Journal of Neurochemistry. 1989;52(2):381\u2013389. doi: 10.1111/j.1471-4159.1989.tb09133.x.", "ArticleIdList": ["10.1111/j.1471-4159.1989.tb09133.x", "2911023"]}, {"Citation": "Dexter D. T., Wells F. R., Lees A. J., et al. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. Journal of Neurochemistry. 1989;52(6):1830\u20131836. doi: 10.1111/j.1471-4159.1989.tb07264.x.", "ArticleIdList": ["10.1111/j.1471-4159.1989.tb07264.x", "2723638"]}, {"Citation": "Yoritaka A., Hattori N., Uchida K., Tanaka M., Stadtman E. R., Mizuno Y. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proceedings of the National Academy of Sciences of the United States of America. 1996;93(7):2696\u20132701. doi: 10.1073/pnas.93.7.2696.", "ArticleIdList": ["10.1073/pnas.93.7.2696", "PMC39693", "8610103"]}, {"Citation": "Floor E., Wetzel M. G. Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay. Journal of Neurochemistry. 1998;70(1):268\u2013275.", "ArticleIdList": ["9422371"]}, {"Citation": "Ihara Y., Chuda D., Kuroda S., Hayabara T. Hydroxyl radical and superoxide dismutase in blood of patients with Parkinson's disease: relationship to clinical data. Journal of the Neurological Sciences. 1999;170(2):90\u201395. doi: 10.1016/s0022-510x(99)00192-6.", "ArticleIdList": ["10.1016/s0022-510x(99)00192-6", "10561523"]}, {"Citation": "Abraham S., Soundararajan C. C., Vivekanandhan S., Behari M. Erythrocyte antioxidant enzymes in Parkinson's disease. Indian Journal of Medical Research. 2005;121(2):111\u2013115.", "ArticleIdList": ["15756044"]}, {"Citation": "Chen C.-M., Liu J.-L., Wu Y.-R., et al. Increased oxidative damage in peripheral blood correlates with severity of Parkinson's disease. Neurobiology of Disease. 2009;33(3):429\u2013435. doi: 10.1016/j.nbd.2008.11.011.", "ArticleIdList": ["10.1016/j.nbd.2008.11.011", "19110057"]}, {"Citation": "Dickson D. W. Linking selective vulnerability to cell death mechanisms in Parkinson's disease. The American Journal of Pathology. 2007;170(1):16\u201319. doi: 10.2353/ajpath.2007.061011.", "ArticleIdList": ["10.2353/ajpath.2007.061011", "PMC1762677", "17200178"]}, {"Citation": "Perry T. L., Godin D. V., Hansen S. Parkinson's disease: a disorder due to nigral glutathione deficiency? Neuroscience Letters. 1982;33(3):305\u2013310. doi: 10.1016/0304-3940(82)90390-1.", "ArticleIdList": ["10.1016/0304-3940(82)90390-1", "7162692"]}, {"Citation": "Sofic E., Lange K. W., Jellinger K., Riederer P. Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease. Neuroscience Letters. 1992;142(2):128\u2013130. doi: 10.1016/0304-3940(92)90355-B.", "ArticleIdList": ["10.1016/0304-3940(92)90355-B", "1454205"]}, {"Citation": "Dias V., Junn E., Mouradian M. M. The role of oxidative stress in parkinson's disease. Journal of Parkinson's Disease. 2013;3(4):461\u2013491. doi: 10.3233/JPD-130230.", "ArticleIdList": ["10.3233/JPD-130230", "PMC4135313", "24252804"]}, {"Citation": "Perry T. L., Yong V. W. Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients. Neuroscience Letters. 1986;67(3):269\u2013274. doi: 10.1016/0304-3940(86)90320-4.", "ArticleIdList": ["10.1016/0304-3940(86)90320-4", "3737015"]}, {"Citation": "Surendran S., Rajasankar S. Parkinson's disease: oxidative stress and therapeutic approaches. Neurological Sciences. 2010;31(5):531\u2013540. doi: 10.1007/s10072-010-0245-1.", "ArticleIdList": ["10.1007/s10072-010-0245-1", "20221655"]}, {"Citation": "Beal M. F. Experimental models of Parkinson's disease. Nature Reviews Neuroscience. 2001;2(5):325\u2013332. doi: 10.1038/35072550.", "ArticleIdList": ["10.1038/35072550", "11331916"]}, {"Citation": "Todd B. S., Ranjita B., Amy K. S., et al. An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered-synuclein metabolism and oxidative damage. The Journal of Neuroscience. 2002;22(16):7006\u20137015.", "ArticleIdList": ["PMC6757862", "12177198"]}, {"Citation": "Pearce R. K. B., Owen A., Daniel S., Jenner P., Marsden C. D. Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease. Journal of Neural Transmission. 1997;104(6-7):661\u2013677. doi: 10.1007/BF01291884.", "ArticleIdList": ["10.1007/BF01291884", "9444566"]}, {"Citation": "Weng J., Tikhonova M. A., Chen J., et al. Ceftriaxone prevents the neurodegeneration and decreased neurogenesis seen in a Parkinson\u2019s disease rat model: an immunohistochemical and MRI study. Behavioural Brain Research. 2016;305:126\u2013139. doi: 10.1016/j.bbr.2016.02.034.", "ArticleIdList": ["10.1016/j.bbr.2016.02.034", "26940602"]}, {"Citation": "Sharma D., Wani W., Sunkaria A., et al. Quercetin attenuates neuronal death against aluminum-induced neurodegeneration in the rat hippocampus. Neuroscience. 2016;324:163\u2013176. doi: 10.1016/j.neuroscience.2016.02.055.", "ArticleIdList": ["10.1016/j.neuroscience.2016.02.055", "26944603"]}, {"Citation": "Saha M. R., Dey P., Begum S., et al. Effect of Acacia catechu (L.f.) willd. on oxidative stress with possible implications in alleviating selected cognitive disorders. PLoS One. 2016;11(3) doi: 10.1371/journal.pone.0150574.e0150574", "ArticleIdList": ["10.1371/journal.pone.0150574", "PMC4780764", "26949964"]}, {"Citation": "Ren R., Shi C., Cao J., et al. Neuroprotective effects of a standardized flavonoid extract of safflower against neurotoxin-induced cellular and animal models of Parkinson's disease. Scientific Reports. 2016;6 doi: 10.1038/srep22135.22135", "ArticleIdList": ["10.1038/srep22135", "PMC4764910", "26906725"]}, {"Citation": "De Pedro N., Cantizani J., Ortiz-L\u00f3pez F. J., et al. Protective effects of isolecanoric acid on neurodegenerative in vitro models. Neuropharmacology. 2016;101:538\u2013548. doi: 10.1016/j.neuropharm.2015.09.029.", "ArticleIdList": ["10.1016/j.neuropharm.2015.09.029", "26455662"]}, {"Citation": "Wu C.-R., Tsai C.-W., Chang S.-W., Lin C.-Y., Huang L.-C., Tsai C.-W. Carnosic acid protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro model of Parkinson's disease: involvement of antioxidative enzymes induction. Chemico-Biological Interactions. 2015;225:40\u201346. doi: 10.1016/j.cbi.2014.11.011.", "ArticleIdList": ["10.1016/j.cbi.2014.11.011", "25446857"]}, {"Citation": "Siddique Y. H., Faisal M., Naz F., Jyoti S., Rahul Role of Ocimum sanctum leaf extract on dietary supplementation in the transgenic Drosophila model of Parkinson's disease. Chinese Journal of Natural Medicines. 2014;12(10):777\u2013781. doi: 10.1016/S1875-5364(14)60118-7.", "ArticleIdList": ["10.1016/S1875-5364(14)60118-7", "25443371"]}, {"Citation": "Antunes M. S., Goes A. T. R., Boeira S. P., Prigol M., Jesse C. R. Protective effect of hesperidin in a model of Parkinson's disease induced by 6-hydroxydopamine in aged mice. Nutrition. 2014;30(11-12):1415\u20131422. doi: 10.1016/j.nut.2014.03.024.", "ArticleIdList": ["10.1016/j.nut.2014.03.024", "25280422"]}, {"Citation": "P\u00e9rez-Barr\u00f3n G., \u00c1vila-Acevedo J. G., Garc\u00eda-Bores A. M., et al. Neuroprotective effect of Buddleja cordata methanolic extract in the 1-methyl-4-phenylpyridinium Parkinson's disease rat model. Journal of Natural Medicines. 2015;69(1):86\u201393. doi: 10.1007/s11418-014-0866-4.", "ArticleIdList": ["10.1007/s11418-014-0866-4", "25253176"]}, {"Citation": "Beppe G. J., Dongmo A. B., Foyet H. S., et al. Memory-enhancing activities of the aqueous extract of Albizia adianthifolia leaves in the 6-hydroxydopamine-lesion rodent model of Parkinson's disease. BMC Complementary and Alternative Medicine. 2014;14, article 142 doi: 10.1186/1472-6882-14-142.", "ArticleIdList": ["10.1186/1472-6882-14-142", "PMC4019966", "24884469"]}, {"Citation": "Gokul K., Muralidhara Oral supplements of aqueous extract of tomato seeds alleviate motor abnormality, oxidative impairments and neurotoxicity induced by rotenone in mice: relevance to Parkinson's disease. Neurochemical Research. 2014;39(7):1382\u20131394. doi: 10.1007/s11064-014-1323-1.", "ArticleIdList": ["10.1007/s11064-014-1323-1", "24831121"]}, {"Citation": "Siddique Y. H., Jyoti S., Naz F. Effect of epicatechin gallate dietary supplementation on transgenic drosophila model of parkinson's disease. Journal of Dietary Supplements. 2014;11(2):121\u2013130. doi: 10.3109/19390211.2013.859207.", "ArticleIdList": ["10.3109/19390211.2013.859207", "24670116"]}, {"Citation": "Khurana N., Gajbhiye A. Ameliorative effect of Sida cordifolia in rotenone induced oxidative stress model of Parkinson's disease. NeuroToxicology. 2013;39:57\u201364. doi: 10.1016/j.neuro.2013.08.005.", "ArticleIdList": ["10.1016/j.neuro.2013.08.005", "23994302"]}, {"Citation": "Chandran G., Muralidhara M. Neuroprotective effect of aqueous extract of selaginella delicatula as evidenced by abrogation of rotenone-induced motor deficits, oxidative dysfunctions, and neurotoxicity in mice. Cellular and Molecular Neurobiology. 2013;33(7):929\u2013942. doi: 10.1007/s10571-013-9959-y.", "ArticleIdList": ["10.1007/s10571-013-9959-y", "23868340"]}, {"Citation": "Prakash J., Yadav S. K., Chouhan S., Singh S. P. Neuroprotective role of withania somnifera root extract in maneb-paraquat induced mouse model of parkinsonism. Neurochemical Research. 2013;38(5):972\u2013980. doi: 10.1007/s11064-013-1005-4.", "ArticleIdList": ["10.1007/s11064-013-1005-4", "23430469"]}, {"Citation": "Mansouri M. T., Farbood Y., Sameri M. J., Sarkaki A., Naghizadeh B., Rafeirad M. Neuroprotective effects of oral gallic acid against oxidative stress induced by 6-hydroxydopamine in rats. Food Chemistry. 2013;138(2-3):1028\u20131033. doi: 10.1016/j.foodchem.2012.11.022.", "ArticleIdList": ["10.1016/j.foodchem.2012.11.022", "23411210"]}, {"Citation": "Shalavadi M. H., Chandrashekhar V. M., Avinash S. P., Sowmya C., Ramkishan A. Neuroprotective activity of Stereospermum suaveolens DC against 6-OHDA induced Parkinson's disease model. Indian Journal of Pharmacology. 2012;44(6):737\u2013743. doi: 10.4103/0253-7613.103275.", "ArticleIdList": ["10.4103/0253-7613.103275", "PMC3523502", "23248404"]}, {"Citation": "Liu S.-M., Li X.-Z., Huo Y., Lu F. Protective effect of extract of Acanthopanax senticosus harms on dopaminergic neurons in Parkinson's disease mice. Phytomedicine. 2012;19(7):631\u2013638. doi: 10.1016/j.phymed.2012.02.006.", "ArticleIdList": ["10.1016/j.phymed.2012.02.006", "22402244"]}, {"Citation": "Anandhan A., Tamilselvam K., Radhiga T., Rao S., Essa M. M., Manivasagam T. Theaflavin, a black tea polyphenol, protects nigral dopaminergic neurons against chronic MPTP/probenecid induced Parkinson's disease. Brain Research. 2012;1433:104\u2013113. doi: 10.1016/j.brainres.2011.11.021.", "ArticleIdList": ["10.1016/j.brainres.2011.11.021", "22138428"]}, {"Citation": "Nataraj J., Manivasagam T., Thenmozhi A. J., Essa M. M. Lutein protects dopaminergic neurons against MPTP-induced apoptotic death and motor dysfunction by ameliorating mitochondrial disruption and oxidative stress. Nutritional Neuroscience. 2016;19(6):237\u2013246. doi: 10.1179/1476830515y.0000000010.", "ArticleIdList": ["10.1179/1476830515y.0000000010", "25730317"]}, {"Citation": "Nataraj J., Manivasagam T., Justin Thenmozhi A., Essa M. M. Neuroprotective effect of asiatic acid on rotenone-induced mitochondrial dysfunction and oxidative stress-mediated apoptosis in differentiated SH-SYS5Y cells. Nutritional Neuroscience. 2016 doi: 10.1080/1028415x.2015.1135559.", "ArticleIdList": ["10.1080/1028415x.2015.1135559", "26856988"]}, {"Citation": "Dhanalakshmi C., Manivasagam T., Nataraj J., Justin Thenmozhi A., Essa M. M. Neurosupportive role of vanillin, a natural phenolic compound, on rotenone induced neurotoxicity in SH-SY5Y neuroblastoma cells. Evidence-Based Complementary and Alternative Medicine. 2015;2015:11. doi: 10.1155/2015/626028.626028", "ArticleIdList": ["10.1155/2015/626028", "PMC4664805", "26664453"]}, {"Citation": "Tamilselvam K., Braidy N., Manivasagam T., et al. Neuroprotective effects of hesperidin, a plant flavanone, on rotenone-induced oxidative stress and apoptosis in a cellular model for Parkinson's disease. Oxidative Medicine and Cellular Longevity. 2013;2013:11. doi: 10.1155/2013/102741.102741", "ArticleIdList": ["10.1155/2013/102741", "PMC3800605", "24205431"]}, {"Citation": "Braidy N., Selvaraju S., Essa M. M., et al. Neuroprotective effects of a variety of pomegranate juice extracts against MPTP-induced cytotoxicity and oxidative stress in human primary neurons. Oxidative Medicine and Cellular Longevity. 2013;2013:12. doi: 10.1155/2013/685909.685909", "ArticleIdList": ["10.1155/2013/685909", "PMC3816068", "24223235"]}, {"Citation": "Ahmad S., Khan M. B., Hoda M. N., et al. Neuroprotective effect of sesame seed oil in 6-hydroxydopamine induced neurotoxicity in mice model: cellular, biochemical and neurochemical evidence. Neurochemical Research. 2012;37(3):516\u2013526. doi: 10.1007/s11064-011-0638-4.", "ArticleIdList": ["10.1007/s11064-011-0638-4", "22089932"]}, {"Citation": "Martins E. N., Pessano N. T. C., Leal L., et al. Protective effect of Melissa officinalis aqueous extract against Mn-induced oxidative stress in chronically exposed mice. Brain Research Bulletin. 2012;87(1):74\u201379. doi: 10.1016/j.brainresbull.2011.10.003.", "ArticleIdList": ["10.1016/j.brainresbull.2011.10.003", "22020131"]}, {"Citation": "Hritcu L., Foyet H. S., Stefan M., Mihasan M., Asongalem A. E., Kamtchouing P. Neuroprotective effect of the methanolic extract of Hibiscus asper leaves in 6-hydroxydopamine-lesioned rat model of Parkinson's disease. Journal of Ethnopharmacology. 2011;137(1):585\u2013591. doi: 10.1016/j.jep.2011.06.008.", "ArticleIdList": ["10.1016/j.jep.2011.06.008", "21704692"]}, {"Citation": "Ranpariya V. L., Parmar S. K., Sheth N. R., Chandrashekhar V. M. Neuroprotective activity of Matricaria recutita against fluoride-induced stress in rats. Pharmaceutical Biology. 2011;49(7):696\u2013701. doi: 10.3109/13880209.2010.540249.", "ArticleIdList": ["10.3109/13880209.2010.540249", "21599496"]}, {"Citation": "Wang Y., Xu H., Fu Q., Ma R., Xiang J. Protective effect of resveratrol derived from Polygonum cuspidatum and its liposomal form on nigral cells in Parkinsonian rats. Journal of the Neurological Sciences. 2011;304(1-2):29\u201334. doi: 10.1016/j.jns.2011.02.025.", "ArticleIdList": ["10.1016/j.jns.2011.02.025", "21376343"]}, {"Citation": "Verma R., Nehru B. Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease. Neurochemistry International. 2009;55(6):369\u2013375. doi: 10.1016/j.neuint.2009.04.001.", "ArticleIdList": ["10.1016/j.neuint.2009.04.001", "19375462"]}, {"Citation": "Kaur H., Chauhan S., Sandhir R. Protective effect of lycopene on oxidative stress and cognitive decline in rotenone induced model of Parkinson's disease. Neurochemical Research. 2011;36(8):1435\u20131443. doi: 10.1007/s11064-011-0469-3.", "ArticleIdList": ["10.1007/s11064-011-0469-3", "21484267"]}, {"Citation": "Khan M. M., Raza S. S., Javed H., et al. Rutin protects dopaminergic neurons from oxidative stress in an animal model of Parkinson's disease. Neurotoxicity Research. 2012;22(1):1\u201315. doi: 10.1007/s12640-011-9295-2.", "ArticleIdList": ["10.1007/s12640-011-9295-2", "22194158"]}, {"Citation": "Essa M. M., Subash S., Dhanalakshmi C., et al. Dietary supplementation of walnut partially reverses 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced neurodegeneration in a mouse model of Parkinson's disease. Neurochemical Research. 2015;40(6):1283\u20131293. doi: 10.1007/s11064-015-1593-2.", "ArticleIdList": ["10.1007/s11064-015-1593-2", "25944473"]}, {"Citation": "Jahromi S. R., Haddadi M., Shivanandappa T., Ramesh S. R. Modulatory effect of Decalepis hamiltonii on ethanol-induced toxicity in transgenic Drosophila model of Parkinson's disease. Neurochemistry International. 2015;80:1\u20136. doi: 10.1016/j.neuint.2014.10.010.", "ArticleIdList": ["10.1016/j.neuint.2014.10.010", "25451756"]}, {"Citation": "Tseng Y.-T., Chang F.-R., Lo Y.-C. The Chinese herbal formula Liuwei dihuang protects dopaminergic neurons against Parkinson's toxin through enhancing antioxidative defense and preventing apoptotic death. Phytomedicine. 2014;21(5):724\u2013733. doi: 10.1016/j.phymed.2013.11.001.", "ArticleIdList": ["10.1016/j.phymed.2013.11.001", "24411708"]}, {"Citation": "Guo B., Xu D., Duan H., et al. Therapeutic effects of multifunctional tetramethylpyrazine nitrone on models of Parkinson's disease in vitro and in vivo. Biological and Pharmaceutical Bulletin. 2014;37(2):274\u2013285. doi: 10.1248/bpb.b13-00743.", "ArticleIdList": ["10.1248/bpb.b13-00743", "24305623"]}, {"Citation": "Sudati J. H., Vieira F. A., Pavin S. S., et al. Valeriana officinalis attenuates the rotenone-induced toxicity in drosophila melanogaster . NeuroToxicology. 2013;37:118\u2013126. doi: 10.1016/j.neuro.2013.04.006.", "ArticleIdList": ["10.1016/j.neuro.2013.04.006", "23639798"]}, {"Citation": "Pasban-Aliabadi H., Esmaeili-Mahani S., Sheibani V., Abbasnejad M., Mehdizadeh A., Yaghoobi M. M. Inhibition of 6-hydroxydopamine-induced PC12 cell apoptosis by olive (Olea europaea L.) leaf extract is performed by its main component oleuropein. Rejuvenation Research. 2013;16(2):134\u2013142. doi: 10.1089/rej.2012.1384.", "ArticleIdList": ["10.1089/rej.2012.1384", "23394606"]}, {"Citation": "Kim K.-H., Song K., Yoon S.-H., Shehzad O., Kim Y.-S., Son J. H. Rescue of PINK1 protein null-specific mitochondrial complex IV deficits by ginsenoside Re activation of nitric oxide signaling. The Journal of Biological Chemistry. 2012;287(53):44109\u201344120. doi: 10.1074/jbc.m112.408146.", "ArticleIdList": ["10.1074/jbc.m112.408146", "PMC3531727", "23144451"]}, {"Citation": "Li S., Pu X.-P. Neuroprotective effect of kaempferol against a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease. Biological and Pharmaceutical Bulletin. 2011;34(8):1291\u20131296. doi: 10.1248/bpb.34.1291.", "ArticleIdList": ["10.1248/bpb.34.1291", "21804220"]}, {"Citation": "Liang Z., Shi F., Wang Y., et al. Neuroprotective effects of tenuigenin in a SH-SY5Y cell model with 6-OHDA-induced injury. Neuroscience Letters. 2011;497(2):104\u2013109. doi: 10.1016/j.neulet.2011.04.041.", "ArticleIdList": ["10.1016/j.neulet.2011.04.041", "21536104"]}, {"Citation": "Hu S., Han R., Mak S., Han Y. Protection against 1-methyl-4-phenylpyridinium ion (MPP+)-induced apoptosis by water extract of ginseng (Panax ginseng C.A. Meyer) in SH-SY5Y cells. Journal of Ethnopharmacology. 2011;135(1):34\u201342. doi: 10.1016/j.jep.2011.02.017.", "ArticleIdList": ["10.1016/j.jep.2011.02.017", "21349320"]}, {"Citation": "Choi J. G., Kim H. G., Kim M. C., et al. Polygalae radix inhibits toxin-induced neuronal death in the Parkinson's disease models. Journal of Ethnopharmacology. 2011;134(2):414\u2013421. doi: 10.1016/j.jep.2010.12.030.", "ArticleIdList": ["10.1016/j.jep.2010.12.030", "21195155"]}, {"Citation": "Sengupta T., Vinayagam J., Nagashayana N., Gowda B., Jaisankar P., Mohanakumar K. P. Antiparkinsonian effects of aqueous methanolic extract of Hyoscyamus niger seeds result from its monoamine oxidase inhibitory and hydroxyl radical scavenging potency. Neurochemical Research. 2011;36(1):177\u2013186. doi: 10.1007/s11064-010-0289-x.", "ArticleIdList": ["10.1007/s11064-010-0289-x", "20972705"]}, {"Citation": "An L., Liu S., Dong Y., Tang B., Dong W. Protective effect of effective part of Acanthopanacis senticosus on damage of PC12 cells induced by MPP+ Zhongguo Zhongyao Zazhi. 2010;35(15):2021\u20132026. doi: 10.4268/cjcmm20101524.", "ArticleIdList": ["10.4268/cjcmm20101524", "20931860"]}, {"Citation": "Kim H. G., Ju M. S., Kim D.-H., et al. Protective effects of Chunghyuldan against ROS-mediated neuronal cell death in models of Parkinson's disease. Basic & Clinical Pharmacology & Toxicology. 2010;107(6):958\u2013964. doi: 10.1111/j.1742-7843.2010.00612.x.", "ArticleIdList": ["10.1111/j.1742-7843.2010.00612.x", "20629656"]}, {"Citation": "Lee C.-H., Hwang D.-S., Kim H. G., et al. Protective effect of Cyperi Rhizoma against 6-hydroxydopamine-induced neuronal damage. Journal of Medicinal Food. 2010;13(3):564\u2013571. doi: 10.1089/jmf.2009.1252.", "ArticleIdList": ["10.1089/jmf.2009.1252", "20521982"]}, {"Citation": "Shu D., He J., Chen J. Neuroprotective effects and mechanisms of Chuanxiong Chatiao pulvis against MPTP-induced dopaminergic neurotoxicity in mice model of parkinson's disease. Zhongguo Zhongyao Zazhi. 2009;34(19):2494\u20132497.", "ArticleIdList": ["20067021"]}, {"Citation": "Shim J. S., Kim H. G., Ju M. S., Choi J. G., Jeong S. Y., Oh M. S. Effects of the hook of Uncaria rhynchophylla on neurotoxicity in the 6-hydroxydopamine model of Parkinson's disease. Journal of Ethnopharmacology. 2009;126(2):361\u2013365. doi: 10.1016/j.jep.2009.08.023.", "ArticleIdList": ["10.1016/j.jep.2009.08.023", "19703534"]}, {"Citation": "Sankar S. R., Manivasagam T., Krishnamurti A., Ramanathan M. The neuroprotective effect of Withania somnifera root extract in MPTP-intoxicated mice: an analysis of behavioral and biochemical varibles. Cellular and Molecular Biology Letters. 2007;12(4):473\u2013481. doi: 10.2478/s11658-007-0015-0.", "ArticleIdList": ["10.2478/s11658-007-0015-0", "PMC6275882", "17415533"]}, {"Citation": "Ahmad M., Yousuf S., Khan M. B., et al. Protective effects of ethanolic extract of Delphinium denudatum in a rat model of Parkinson's disease. Human and Experimental Toxicology. 2006;25(7):361\u2013368. doi: 10.1191/0960327106ht635oa.", "ArticleIdList": ["10.1191/0960327106ht635oa", "16898164"]}, {"Citation": "Ahmad M., Yousuf S., Khan M. B., et al. Attenuation by Nardostachys jatamansi of 6-hydroxydopamine-induced parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies. Pharmacology Biochemistry and Behavior. 2006;83(1):150\u2013160. doi: 10.1016/j.pbb.2006.01.005.", "ArticleIdList": ["10.1016/j.pbb.2006.01.005", "16500697"]}, {"Citation": "Zhang S., Shao S.-Y., Song X.-Y., et al. Protective effects of Forsythia suspense extract with antioxidant and anti-inflammatory properties in a model of rotenone induced neurotoxicity. NeuroToxicology. 2016;52:72\u201383. doi: 10.1016/j.neuro.2015.09.009.", "ArticleIdList": ["10.1016/j.neuro.2015.09.009", "26408940"]}, {"Citation": "Lu K.-T., Ko M.-C., Chen B.-Y., et al. Neuroprotective effects of resveratrol on MPTP-induced neuron loss mediated by free radical scavenging. Journal of Agricultural and Food Chemistry. 2008;56(16):6910\u20136913. doi: 10.1021/jf8007212.", "ArticleIdList": ["10.1021/jf8007212", "18616261"]}, {"Citation": "Mythri R. B., Srinivas Bharath M. M. Curcumin: a potential neuroprotective agent in Parkinson's disease. Current Pharmaceutical Design. 2012;18(1):91\u201399. doi: 10.2174/138161212798918995.", "ArticleIdList": ["10.2174/138161212798918995", "22211691"]}, {"Citation": "Szlachcic W. J., Switonski P. M., Krzyzosiak W. J., Figlerowicz M., Figiel M. Huntington disease iPSCs show early molecular changes in intracellular signaling, the expression of oxidative stress proteins and the p53 pathway. DMM Disease Models and Mechanisms. 2015;8(9):1047\u20131057. doi: 10.1242/dmm.019406.", "ArticleIdList": ["10.1242/dmm.019406", "PMC4582098", "26092128"]}, {"Citation": "Li X., Valencia A., Sapp E., et al. Aberrant Rab11-dependent trafficking of the neuronal glutamate transporter EAAC1 causes oxidative stress and cell death in Huntington's disease. Journal of Neuroscience. 2010;30(13):4552\u20134561. doi: 10.1523/jneurosci.5865-09.2010.", "ArticleIdList": ["10.1523/jneurosci.5865-09.2010", "PMC3842456", "20357106"]}, {"Citation": "Sari Y. Huntington's disease: from mutant huntingtin protein to neurotrophic factor therapy. International Journal of Biomedical Science. 2011;7(2):89\u2013100.", "ArticleIdList": ["PMC3154262", "21841917"]}, {"Citation": "Walker F. O. Huntington's disease. Lancet. 2007;369(9557):218\u2013228. doi: 10.1016/S0140-6736(07)60111-1.", "ArticleIdList": ["10.1016/S0140-6736(07)60111-1", "17240289"]}, {"Citation": "Rotblat B., Southwell A. L., Ehrnhoefer D. E., et al. HACE1 reduces oxidative stress and mutant Huntingtin toxicity by promoting the NRF2 response. Proceedings of the National Academy of Sciences of the United States of America. 2014;111(8):3032\u20133037. doi: 10.1073/pnas.1314421111.", "ArticleIdList": ["10.1073/pnas.1314421111", "PMC3939919", "24516159"]}, {"Citation": "Johri A., Beal M. F. Antioxidants in Huntington's disease. Biochimica et Biophysica Acta. 2012;1822(5):664\u2013674. doi: 10.1016/j.bbadis.2011.11.014.", "ArticleIdList": ["10.1016/j.bbadis.2011.11.014", "PMC3303936", "22138129"]}, {"Citation": "Trushina E., McMurray C. T. Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases. Neuroscience. 2007;145(4):1233\u20131248. doi: 10.1016/j.neuroscience.2006.10.056.", "ArticleIdList": ["10.1016/j.neuroscience.2006.10.056", "17303344"]}, {"Citation": "Sayre L. M., Perry G., Smith M. A. Oxidative stress and neurotoxicity. Chemical Research in Toxicology. 2008;21(1):172\u2013188. doi: 10.1021/tx700210j.", "ArticleIdList": ["10.1021/tx700210j", "18052107"]}, {"Citation": "Lee D.-H., Gold R., Linker R. A. Mechanisms of oxidative damage in multiple sclerosis and neurodegenerative diseases: therapeutic modulation via fumaric acid esters. International Journal of Molecular Sciences. 2012;13(9):11783\u201311803. doi: 10.3390/ijms130911783.", "ArticleIdList": ["10.3390/ijms130911783", "PMC3472775", "23109883"]}, {"Citation": "Chen C.-M., Wu Y.-R., Cheng M.-L., et al. Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington's disease patients. Biochemical and Biophysical Research Communications. 2007;359(2):335\u2013340. doi: 10.1016/j.bbrc.2007.05.093.", "ArticleIdList": ["10.1016/j.bbrc.2007.05.093", "17543886"]}, {"Citation": "Choudhary S., Kumar P., Malik J. Plants and phytochemicals for Huntington\u2032s disease. Pharmacognosy Reviews. 2013;7(14):81\u201391. doi: 10.4103/0973-7847.120505.", "ArticleIdList": ["10.4103/0973-7847.120505", "PMC3841999", "24347915"]}, {"Citation": "Gu M., Gash M. T., Mann V. M., Javoy-Agid F., Cooper J. M., Schapira A. H. V. Mitochondrial defect in Huntington's disease caudate nucleus. Annals of Neurology. 1996;39(3):385\u2013389. doi: 10.1002/ana.410390317.", "ArticleIdList": ["10.1002/ana.410390317", "8602759"]}, {"Citation": "T\u00fanez I., S\u00e1nchez-L\u00f3pez F., Ag\u00fcera E., Fern\u00e1ndez-Bola\u00f1os R., S\u00e1nchez F. M., Tasset-Cuevas I. Important role of oxidative stress biomarkers in Huntington's disease. Journal of Medicinal Chemistry. 2011;54(15):5602\u20135606. doi: 10.1021/jm200605a.", "ArticleIdList": ["10.1021/jm200605a", "21678912"]}, {"Citation": "Klepac N., Relja M., Klepac R., He\u0107imovi\u0107 S., Babi\u0107 T., Trkulja V. Oxidative stress parameters in plasma of Huntington's disease patients, asymptomatic Huntington's disease gene carriers and healthy subjects: a cross-sectional study. Journal of Neurology. 2007;254(12):1676\u20131683. doi: 10.1007/s00415-007-0611-y.", "ArticleIdList": ["10.1007/s00415-007-0611-y", "17990062"]}, {"Citation": "Goula A.-V., Berquist B. R., Wilson D. M., III, Wheeler V. C., Trottier Y., Merienne K. Stoichiometry of base excision repair proteins correlates with increased somatic CAG instability in striatum over cerebellum in Huntington's disease transgenic mice. PLoS Genetics. 2009;5(12) doi: 10.1371/journal.pgen.1000749.e1000749", "ArticleIdList": ["10.1371/journal.pgen.1000749", "PMC2778875", "19997493"]}, {"Citation": "Browne S. E., Bowling A. C., MacGarvey U., et al. Oxidative damage and metabolic dysfunction in huntington's disease: selective vulnerability of the basal ganglia. Annals of Neurology. 1997;41(5):646\u2013653. doi: 10.1002/ana.410410514.", "ArticleIdList": ["10.1002/ana.410410514", "9153527"]}, {"Citation": "Ribeiro M., Rosenstock T. R., Cunha-Oliveira T., Ferreira I. L., Oliveira C. R., Rego A. C. Glutathione redox cycle dysregulation in Huntington's disease knock-in striatal cells. Free Radical Biology and Medicine. 2012;53(10):1857\u20131867. doi: 10.1016/j.freeradbiomed.2012.09.004.", "ArticleIdList": ["10.1016/j.freeradbiomed.2012.09.004", "22982598"]}, {"Citation": "Stoy N., Mackay G. M., Forrest C. M., et al. Tryptophan metabolism and oxidative stress in patients with Huntington's disease. Journal of Neurochemistry. 2005;93(3):611\u2013623. doi: 10.1111/j.1471-4159.2005.03070.x.", "ArticleIdList": ["10.1111/j.1471-4159.2005.03070.x", "15836620"]}, {"Citation": "Duran R., Barrero F. J., Morales B., Luna J. D., Ramirez M., Vives F. Oxidative stress and plasma aminopeptidase activity in Huntington's disease. Journal of Neural Transmission. 2010;117(3):325\u2013332. doi: 10.1007/s00702-009-0364-0.", "ArticleIdList": ["10.1007/s00702-009-0364-0", "20094738"]}, {"Citation": "Oliveira A. M., Cardoso S. M., Ribeiro M., Seixas R. S. G. R., Silva A. M. S., Rego A. C. Protective effects of 3-alkyl luteolin derivatives are mediated by Nrf2 transcriptional activity and decreased oxidative stress in Huntington's disease mouse striatal cells. Neurochemistry International. 2015;91:1\u201312. doi: 10.1016/j.neuint.2015.10.004.", "ArticleIdList": ["10.1016/j.neuint.2015.10.004", "26476055"]}, {"Citation": "Shivasharan B. D., Nagakannan P., Thippeswamy B. S., Veerapur V. P., Bansal P., Unnikrishnan M. K. Protective effect of Calendula officinalis Linn. flowers against 3-nitropropionic acid induced experimental Huntington's disease in rats. Drug and Chemical Toxicology. 2013;36(4):466\u2013473. doi: 10.3109/01480545.2013.776583.", "ArticleIdList": ["10.3109/01480545.2013.776583", "23590827"]}, {"Citation": "Mahdy H. M., Tadros M. G., Mohamed M. R., Karim A. M., Khalifa A. E. The effect of Ginkgo biloba extract on 3-nitropropionic acid-induced neurotoxicity in rats. Neurochemistry International. 2011;59(6):770\u2013778. doi: 10.1016/j.neuint.2011.07.012.", "ArticleIdList": ["10.1016/j.neuint.2011.07.012", "21827809"]}, {"Citation": "Tasset I., Pontes A. J., Hinojosa A. J., de la Torre R., T\u00fanez I. Olive oil reduces oxidative damage in a 3-nitropropionic acid-induced huntington's disease-like rat model. Nutritional Neuroscience. 2011;14(3):106\u2013111. doi: 10.1179/1476830511Y.0000000005.", "ArticleIdList": ["10.1179/1476830511Y.0000000005", "21756531"]}, {"Citation": "Sagredo O., Pazos M. R., Satta V., Ramos J. A., Pertwee R. G., Fern\u00e1ndez-Ruiz J. Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease. Journal of Neuroscience Research. 2011;89(9):1509\u20131518. doi: 10.1002/jnr.22682.", "ArticleIdList": ["10.1002/jnr.22682", "21674569"]}, {"Citation": "Gao Y., Chu S.-F., Li J.-P., et al. Protopanaxtriol protects against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington's disease. Acta Pharmacologica Sinica. 2015;36(3):311\u2013322. doi: 10.1038/aps.2014.107.", "ArticleIdList": ["10.1038/aps.2014.107", "PMC4349920", "25640478"]}, {"Citation": "T\u00fanez I., Montilla P., Del Carmen Mu\u00f1oz M., Feij\u00f3o M., Salcedo M. Protective effect of melatonin on 3-nitropropionic acid-induced oxidative stress in synaptosomes in an animal model of Huntington's disease. Journal of Pineal Research. 2004;37(4):252\u2013256. doi: 10.1111/j.1600-079x.2004.00163.x.", "ArticleIdList": ["10.1111/j.1600-079x.2004.00163.x", "15485551"]}, {"Citation": "Rocha-Gonz\u00e1lez H. I., Ambriz-Tututi M., Granados-Soto V. Resveratrol: a natural compound with pharmacological potential in neurodegenerative diseases. CNS Neuroscience and Therapeutics. 2008;14(3):234\u2013247. doi: 10.1111/j.1755-5949.2008.00045.x.", "ArticleIdList": ["10.1111/j.1755-5949.2008.00045.x", "PMC6494027", "18684235"]}, {"Citation": "Andreassen O. A., Ferrante R. J., Dedeoglu A., Beal M. F. Lipoic acid improves survival in transgenic mouse models of Huntington's disease. NeuroReport. 2001;12(15):3371\u20133373. doi: 10.1097/00001756-200110290-00044.", "ArticleIdList": ["10.1097/00001756-200110290-00044", "11711888"]}, {"Citation": "Ehrnhoefer D. E., Duennwald M., Markovic P., et al. Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models. Human Molecular Genetics. 2006;15(18):2743\u20132751. doi: 10.1093/hmg/ddl210.", "ArticleIdList": ["10.1093/hmg/ddl210", "16893904"]}, {"Citation": "Denny Joseph K. M., Muralidhara Enhanced neuroprotective effect of fish oil in combination with quercetin against 3-nitropropionic acid induced oxidative stress in rat brain. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2013;40(1):83\u201392. doi: 10.1016/j.pnpbp.2012.08.018.", "ArticleIdList": ["10.1016/j.pnpbp.2012.08.018", "22960609"]}, {"Citation": "Fu J., Jin J., Cichewicz R. H., et al. Trans-(-)-\u03b5-viniferin increases mitochondrial sirtuin 3 (SIRT3), activates AMP-activated protein kinase (AMPK), and protects cells in models of huntington disease. Journal of Biological Chemistry. 2012;287(29):24460\u201324472. doi: 10.1074/jbc.m112.382226.", "ArticleIdList": ["10.1074/jbc.m112.382226", "PMC3397871", "22648412"]}, {"Citation": "Huang N., Lin J., Lin J., et al. A new drug design targeting the adenosinergic system for Huntington's disease. PLoS ONE. 2011;6(6) doi: 10.1371/journal.pone.0020934.20934", "ArticleIdList": ["10.1371/journal.pone.0020934", "PMC3119665", "21713039"]}, {"Citation": "Ranpariya V. L., Parmar S. K., Sheth N. R., Chandrashekhar V. M. Neuroprotective activity of Matricaria recutita against fluoride-induced stress in rats. Pharmaceutical Biology. 2011;49(7):696\u2013701. doi: 10.3109/13880209.2010.540249.", "ArticleIdList": ["10.3109/13880209.2010.540249", "21599496"]}, {"Citation": "Kumar P., Kumar A. Possible neuroprotective effect of withania somnifera root extract against 3-Nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of huntington's disease. Journal of Medicinal Food. 2009;12(3):591\u2013600. doi: 10.1089/jmf.2008.0028.", "ArticleIdList": ["10.1089/jmf.2008.0028", "19627208"]}, {"Citation": "Shinomol G. K., Muralidhara Prophylactic neuroprotective property of Centella asiatica against 3-nitropropionic acid induced oxidative stress and mitochondrial dysfunctions in brain regions of prepubertal mice. NeuroToxicology. 2008;29(6):948\u2013957. doi: 10.1016/j.neuro.2008.09.009.", "ArticleIdList": ["10.1016/j.neuro.2008.09.009", "18930762"]}, {"Citation": "Kaur M., Prakash A., Kalia A. N. Neuroprotective potential of antioxidant potent fractions from Convolvulus pluricaulis Chois. in 3-nitropropionic acid challenged rats. Nutritional Neuroscience. 2016;19(2):70\u201378. doi: 10.1179/1476830515y.0000000022.", "ArticleIdList": ["10.1179/1476830515y.0000000022", "25896328"]}, {"Citation": "Al-Sabahi B. N., Fatope M. O., Essa M. M., et al. Pomegranate seed oil: effect on 3-nitropropionic acid-induced neurotoxicity in PC12 cells and elucidation of unsaturated fatty acids composition. Nutritional Neuroscience. 2017;20(1):40\u201348. doi: 10.1179/1476830514y.0000000155.", "ArticleIdList": ["10.1179/1476830514y.0000000155", "25238165"]}]}], "History": [{"Year": "2016", "Month": "7", "Day": "8"}, {"Year": "2016", "Month": "10", "Day": "6"}, {"Year": "2016", "Month": "11", "Day": "13"}, {"Year": "2017", "Month": "1", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "1", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "3", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "12", "Day": "27"}], "PublicationStatus": "ppublish", "ArticleIdList": ["28116038", "PMC5223034", "10.1155/2016/8590578"]}}]}